Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Current Assets: 2016-2025

Historic Current Assets for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $599.8 million.

  • Tg Therapeutics' Current Assets rose 4.48% to $599.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $599.8 million, marking a year-over-year increase of 4.48%. This contributed to the annual value of $566.4 million for FY2024, which is 78.13% up from last year.
  • Tg Therapeutics' Current Assets amounted to $599.8 million in Q3 2025, which was down 9.67% from $664.0 million recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Current Assets registered a high of $664.0 million during Q2 2025, and its lowest value of $168.3 million during Q4 2022.
  • Over the past 3 years, Tg Therapeutics' median Current Assets value was $389.1 million (recorded in 2024), while the average stood at $439.0 million.
  • Its Current Assets has fluctuated over the past 5 years, first surged by 507.86% in 2021, then slumped by 55.49% in 2022.
  • Over the past 5 years, Tg Therapeutics' Current Assets (Quarterly) stood at $331.0 million in 2021, then crashed by 49.16% to $168.3 million in 2022, then surged by 88.94% to $317.9 million in 2023, then soared by 78.13% to $566.4 million in 2024, then climbed by 4.48% to $599.8 million in 2025.
  • Its Current Assets stands at $599.8 million for Q3 2025, versus $664.0 million for Q2 2025 and $644.5 million for Q1 2025.